Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02891161 |
|---|---|
| Brief Title: | Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder (DUART) |
| First Submitted : | September 1, 2016 |
| First Submitted that Met QC Criteria : | September 1, 2016 |
| First Posted : | September 7, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 5, 2021 |
| Last Update Posted : | February 8, 2021 |